| Term 
 | Definition 
 
        | -direct acting adrenomimetic -low oral bioavailability and short half life
 -EPi can be used for hemorrhage from minor cuts by binding to alpha 1
 -Epi used for combination with local anesthetics
 -used for AV block; V-fib
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct acting adrenomimetic prodrug converted into epinephrine
 topical, ophthalmic agent
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct acting adrenomimetic activates dopamine, B1, alpha receptors
 
 use in distributive shock
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha one selective agonist direct acting adrenomimetic
 
 nasal decongestant
 short duration of action
 
 used for PSVT (paroxysmal supraventricular tachycardia)
 -used for dilation pupil without cycloplegia (paralysis ciliary m.)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha one selective agonist direct acting adrenomimetic
 
 nasal decongestant
 long duration of action
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha one selective agonist direct acting adrenomimetic
 
 nasal decongestant
 long duration of action
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha one selective agonist direct acting adrenomimetic
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha two selective agonist direct acting adrenomimetic
 topical-eye
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | alpha two selective agonist direct acting adrenomimetic
 topical-eye
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | non-selective beta agonist 
 Better than dobutamine for decreasing PVR
 used for AV block
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | B1 agonist; can also activate B2 to a lesser degree 
 used in cardiogenic shock
 |  | 
        |  | 
        
        | Term 
 
        | which drug will have a greater effect on lowering PVR (isoproterenol or dobutamine)? |  | Definition 
 
        | isoproternol; more activity on B2 receptors-->vasodilation |  | 
        |  | 
        
        | Term 
 
        | MOA of direct acting adrenomimetics? |  | Definition 
 
        | directly activate adrenergic receptors |  | 
        |  | 
        
        | Term 
 
        | what would be the advantage of vasoconstricting blood vessels in the area where a local anesthetic is applied? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what's the problem with chronic use of alpha agonists? |  | Definition 
 
        | rebound nasal congestion 
 chronic activation of alpha1 receptor on the nasal mucosa causes down regulation of the receptor; when the drug is stopped, there is insufficient endogenous NE to activate the few receptors that remain; this causes rebound nasal congestion
 |  | 
        |  | 
        
        | Term 
 
        | what's effect of Epi on angioedema (swelling in SubQ tissue cuases non-piting edema) 
 anaphylaxis
 |  | Definition 
 
        | alpha1-constricts capillary beds; counteracts the dilation and increased vascular permeability of capillaries |  | 
        |  | 
        
        | Term 
 
        | what's epi effect on bronchoconstriction (in relation to anaphylaxis)? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what's epi effect on pruritis, urticaria (from anaphylaxis)? |  | Definition 
 
        | beta-suppress release of mediators from mast cells |  | 
        |  | 
        
        | Term 
 
        | what's epi effect on hypotension (from anaphylaxis)? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Why is NE not the drug of choice for anaphylaxis? |  | Definition 
 
        | little effect on bronchoconstriction 
 NE doesn't bind to Beta2 very well
 |  | 
        |  | 
        
        | Term 
 
        | why does standing on your head cardiovert SVT? |  | Definition 
 
        | increases vagal outflow and slows down AV nod to break the circle to get normal sinus rhythm |  | 
        |  | 
        
        | Term 
 
        | PSVT treatment with alpha1 agonist summary |  | Definition 
 
        | main form PSVT is AV nodeal reentry; blocking or slowingdown the AV node will stop this arrhythmia; PE will cause vasoconstriction and increase bp, which is sensed by the baroreceptors, which increase PS activity to the heart; activation of M recpetors on the AV node, slows the AV node, thereby stopping the arrhythmia; this effect (increasing PS stimulation to the heart and stopping PSVT) can be mimicked by vagal maneuvers |  | 
        |  | 
        
        | Term 
 
        | what's the problem with using PE (phenylephrine)to treat PSVT? |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -direct acting adrenomimetic -low oral bioavailability and short half life
 -NE used for hypovolemic and distributive (e.g. septic) shock
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct activating adrenomimetic Beta2 selective agonist
 -used for asthma/COPD
 -short duration of action
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct activating adrenomimetic Beta2 selective agonist
 -used for asthma/COPD
 -used for premature labor (activates uterine smooth muscle relaxtion and stops uterine contractions)
 
 don't use:
 -parenteral form for prevention of preterm labor or treatment of preterm labor beyond 48-72 hour
 -oral form for preterm labor
 -short duration of action
 MI, arrhythmia, tachcardia/death
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | direct activating adrenomimetic Beta2 selective agonist
 -used for asthma/COPD
 -long duration of action
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Beta2 selective agonist -used for asthma/COPD
 -long duration of action
 |  | 
        |  | 
        
        | Term 
 
        | what's the advantage of giving albuterol vs. epi/isoproterenol to treat asthma? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the contraindications for direct acting adrenomimetics? |  | Definition 
 
        | CV disease, hyperthyroidism, diabetes |  | 
        |  | 
        
        | Term 
 
        | what's the MOA for diret acting adrenomimetics? |  | Definition 
 
        | directly activate adrenergic receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | indirect acting adrenomimetics -NOT A DRUG
 -comes from gut bacteria and fermented food
 metabolized by MAO
 -promotes release of NE from sympathetic nerve terminal
 |  | 
        |  | 
        
        | Term 
 
        | what happens if pereson is takin a drug that inhibits the activity of MAO ahd eats a lot of cheese and drinks a lot of beer? |  | Definition 
 
        | BP increases and go into hypertensive crisis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mixed acting adrenomimetic 
 -releases NE from nerve terminal
 -activates alpha and beta receptors
 -crosses BBB
 
 -used fpr asthma, COPD, nasal congestion
 -adverse effects: excessive simtulation B1 results in stroke, MI, sudden death; CNS-insomnia, nervousness, anxiety
 |  | 
        |  | 
        
        | Term 
 
        | what classes of drugs are used for nasal congestion? |  | Definition 
 
        | alpha agonists; ephedrine (mixed acting adrenomimetic) |  | 
        |  | 
        
        | Term 
 
        | ephedrine seldom used to treat asthma; why? |  | Definition 
 
        | side effects and development of B2 agonists |  | 
        |  | 
        
        | Term 
 
        | FDA ban on ephedrine alkaloids doesn't contain? |  | Definition 
 
        | OTC or prescriptoin drugs that contain ephedrine alkaloids or synthetic ephedrine (mild asthma, nasal decongestant) -doesn't include use ephedra in traditional asian medicine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | mixed acting adrenomimetics -directly activates alpha and to lesser extent B
 -release NE from nerve terminal
 -less CNS effectts than ephedrine
 -used as nasal decongestant
 |  | 
        |  |